Leadership Overview
LivaNova has 5 executives leading key functions including technology, information systems, and regional operations.
Driven by innovation in medical technology, LivaNova is dedicated to developing therapeutic solutions that improve patient outcomes and enhance quality of life across its global operations.
Driven by innovation in medical technology, LivaNova is dedicated to developing therapeutic solutions that improve patient outcomes and enhance quality of life across its global operations.
Leadership Roles at LivaNova
Paul Buckman - President, North America
Paul Buckman, the President, North America at LivaNova, directs all commercial and operational activities within the North American region. Buckman oversees the strategic deployment of LivaNova's therapeutic solutions, including products for cardiopulmonary support and neuromodulation, across the United States and Canada. This leadership role involves driving market penetration, managing sales channels, and ensuring customer satisfaction for hospitals and healthcare providers. By cultivating strong relationships with key stakeholders, Paul Buckman ensures LivaNova's advanced medical devices reach patients who need them most. The President, North America's efforts are vital for expanding the company's footprint and reinforcing its commitment to improving patient outcomes across the continent.

Christina Lu - President (China)
Christina Lu, the President (China) at LivaNova, leads the company's strategic initiatives and market development within the critical Chinese region. Lu is responsible for expanding LivaNova's presence and ensuring the successful adoption of its innovative medical devices, including those for cardiopulmonary and neuromodulation applications. This executive function involves navigating the unique regulatory landscape and market dynamics of China to drive revenue growth and patient access. By fostering local partnerships and adapting global strategies to regional needs, Christina Lu plays a pivotal role in LivaNova's international expansion. The President (China)'s leadership is essential for capitalizing on the significant opportunities within this key global market.

Catherine Sheng - President
Catherine Sheng, the President at LivaNova, drives the company's strategic growth and operational excellence across key global markets. Sheng oversees the integration of LivaNova's diverse product portfolio, encompassing cardiopulmonary, neuromodulation, and advanced circulatory support solutions. This executive responsibility involves aligning business objectives with market demands and ensuring the efficient delivery of life-changing medical technologies. By championing innovation and fostering cross-functional collaboration, Catherine Sheng enhances LivaNova's competitive position and commitment to patient well-being. The President's focus on strategic execution is fundamental to achieving the company's mission of improving global health outcomes.
Sai Yedavelli - Chief Information Officer
Sai Yedavelli, the Chief Information Officer at LivaNova, directs the company's global information technology strategy and infrastructure. Overseeing all aspects of digital operations, Yedavelli ensures the secure and efficient management of data critical to LivaNova's medical device development and manufacturing processes. This leadership role involves architecting scalable IT solutions that support the Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. By optimizing enterprise systems and cybersecurity measures, Sai Yedavelli directly enhances operational resilience and supports the company's mission to deliver life-saving therapeutic solutions worldwide. The Chief Information Officer's focus remains on leveraging technology to drive innovation and maintain a competitive edge in the medical device industry.

Dan Suarasan - Chief Technology Officer
Dan Suarasan, the Chief Technology Officer at LivaNova, spearheads the company's technological vision and innovation pipeline. Suarasan guides the research and development efforts across all business segments, focusing on advancing the capabilities of LivaNova's therapeutic solutions. This executive position involves translating cutting-edge scientific discoveries into tangible medical devices, particularly for the Cardiopulmonary and Neuromodulation divisions. By fostering a culture of technological excellence, Dan Suarasan ensures LivaNova remains at the forefront of medical device engineering. The Chief Technology Officer's strategic direction is crucial for developing next-generation products that address unmet clinical needs and improve patient care globally.
Explore Leadership Teams in Manufacturing
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership
PF
KD
TM
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



Edwards Lifesciences is a global medical technology company focused on developing innovative solutions for structural heart disease and critical care monitoring. The company is dedicated to improving patient outcomes through advanced technologies, clinical research, and close collaboration with healthcare professionals. Its mission centers on delivering life-changing therapies that address serious cardiovascular conditions, particularly those involving the hearts valves and structural components.
Company Leadership



CAIRE, headquartered in Ball Ground, Georgia, is a manufacturer of oxygen supply equipment. They specialize in stationary and portable oxygen concentrators.
Company Leadership FH
RA
MM
YS